Gilead Sciences, Inc.
ANTIVIRAL COMPOUNDS
Last updated:
Abstract:
The present disclosure provides compounds for treating a variety of diseases, such as respiratory syncytial virus (RSV), HRV, hMPV, Ebola, Zika, West Nile, Dengue, and HCV.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2021
Issue date:
16 Sep 2021